PROBLEM: Women with certain types of benign breast tumors are at risk of developing breast cancer. There are currently no diagnostic tools available to identify who these women are.
SOLUTION: SilBiotech is developing a diagnostic tool to stop breast cancers from happening to women who are first diagnosed with benign tumors.
IMPACT: This could prevent about 20-25% of breast cancers, saving 40,000 women each year.